Literature DB >> 1952854

Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.

I Odenholt-Tornqvist1, E Löwdin, O Cars.   

Abstract

The pharmacodynamic effects of subinhibitory concentrations of different beta-lactam antibiotics were investigated. A postantibiotic effect (PAE) was induced for different bacterial species by exposure to 10x MIC of several beta-lactam antibiotics for 2 h in vitro. The antibiotic-bacterial combinations used in this study were imipenem-Pseudomonas aeruginosa, benzylpenicillin-Streptococcus pneumoniae and -Streptococcus pyogenes, cefcanel-S. pyogenes, ampicillin-Escherichia coli, and piperacillin-E. coli. After the induction of the PAE, the exposed cultures as well as the unexposed controls were washed and diluted. Thereafter, the cultures in the postantibiotic phase (PA phase) and the cultures not previously treated with antibiotics were exposed to 0.1, 0.2, and 0.3x MIC of the relevant drug and the growth curves were compared. When bacteria in the PA phase were exposed to sub-MICs, a substantial prolongation of the time before regrowth was demonstrated, especially in antibiotic-bacterial combinations for which a PAE was found. In contrast, sub-MICs on cultures not previously exposed to suprainhibitory antibiotic concentrations yielded only a slight reduction in growth rate compared with the controls. Thus, it seems important to distinguish the direct effects of sub-MICs on bacteria not previously exposed to suprainhibitory concentrations from the effects of sub-MICs on bacteria in the PA phase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952854      PMCID: PMC245277          DOI: 10.1128/AAC.35.9.1834

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo.

Authors:  I Odenholt; S E Holm; O Cars
Journal:  J Antimicrob Chemother       Date:  1990-08       Impact factor: 5.790

Review 2.  Interactions between antibiotics and phagocytosis in bacterial killing.

Authors:  P Van der Auwera
Journal:  Scand J Infect Dis Suppl       Date:  1990

3.  The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Ann Intern Med       Date:  1950-09       Impact factor: 25.391

4.  Impact of dosage regimens on the efficacy of antibiotics in the immunocompromised host.

Authors:  I A Bakker-Woudenberg; R Roosendaal
Journal:  J Antimicrob Chemother       Date:  1988-02       Impact factor: 5.790

5.  Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro.

Authors:  I Odenholt; S E Holm; O Cars
Journal:  J Antimicrob Chemother       Date:  1989-08       Impact factor: 5.790

6.  Effect of subinhibitory concentrations of antibiotics on the adhesion of Streptococcus pyogenes to pharyngeal epithelial cells.

Authors:  S Tylewska; S Hjertén; T Wadström
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

7.  Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus.

Authors:  T Oshida; T Onta; N Nakanishi; T Matsushita; T Yamaguchi
Journal:  J Antimicrob Chemother       Date:  1990-07       Impact factor: 5.790

8.  Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.

Authors:  A U Gerber; H P Brugger; C Feller; T Stritzko; B Stalder
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

9.  Effects of ten milligrams of ampicillin per day on urinary tract infections.

Authors:  S B Redjeb; A Slim; A Horchani; S Zmerilli; A Boujnah; V Lorian
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

10.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
View more
  33 in total

1.  Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.

Authors:  P C Braga; M T Sala; M Dal Sasso
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.

Authors:  L Aguilar; M Martín; I P Balcabao; M L Gómez-Lus; R Dal-Ré; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.

Authors:  K Fuursted; J D Knudsen; M B Petersen; R L Poulsen; D Rehm
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.

Authors:  P D Lister; A Pong; S A Chartrand; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

6.  Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.

Authors:  S K Spangler; G Lin; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 7.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

8.  Pharmacodynamic effects of meropenem on gram-negative bacteria.

Authors:  H Hanberger; E Svensson; L E Nilsson; M Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

9.  Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens.

Authors:  I Odenholt-Tornqvist; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.

Authors:  B J McGrath; K C Lamp; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.